Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM). In the first trial, a small pilot study ...

DENVER, April 15, 2025 /PRNewswire/ -- Revelstoke Capital Partners ("Revelstoke"), a growth-oriented healthcare-focused private equity firm, announced today it completed a recapitalization of AOM ...

Background: Because resolution of symptoms is a primary goal of antimicrobial therapy in children with acute otitis media (AOM), measurement of symptoms in studies of antimicrobial effectiveness ...